Unique pharmaceutical residues removal plant upgraded

The initial delivery comprised pilot treatment, mechanical design, engineering consulting, installation and commissioning.

Now, more than a successful year later of operating the full-scale active pharmaceutical ingredients (API) removal plant for their wastewater, our client has opted to increase the treatment capacity. It is now time to adapt the future API production increase.

The full system, combining UF and ozonation, for fatty acid separation and destruction of more than 10 ppm propofol solved the regional emission restrictions imposed on the plant.

We have already started the process of an upgrade to double the capacity for the entire system and look forward to serving the factory and the environment once again during the coming weeks.